Guardant Health Profit Margin

Guardant Health (GH) currently reports a profit margin of -38.33% as of June 2026. That compares with -49.93% in the prior-year period — up 23.2% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Guardant Health's profit margin history and peer comparisons.

Guardant Health's profit margin increased from -49.93% to -38.33% — a 23.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Guardant Health's profit margin of -38.33% is lower than the Healthcare sector average of 21.34%. That is roughly 279.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Guardant Health's current -38.33% should be judged against Healthcare norms (sector average: 21.34%) and against GH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -38.33%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Guardant Health, and consider following GH for alerts when major investors trade the stock.